actavis - BingNewshttp://www.bing.com/news/search?q=actavis&setmkt=en-US&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifactavishttp://www.bing.com/news/search?q=actavis&setmkt=en-US&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.Actavis buying Warner Chilcott in $8.5B dealhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.yahoo.com%2fnews%2factavis-buying-warner-chilcott-8-112514305.html&c=5575992772809009913&mkt=en-usNEW YORK (AP) -- Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. The ...Mon, 20 May 2013 15:36:00 GMTYahooIs It Time to Buy Actavis plc Stock?http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2014%2f09%2f08%2fis-it-time-to-buy-actavis-plc-stock.aspx&c=17899565218594815222&mkt=en-usWhile the sector at large has performed well of late, certain companies such as Actavis plc (ACT +0.00%) have still beaten the broader market by leaps and bounds, as the following chart shows. Actavis ...Mon, 08 Sep 2014 12:15:00 GMTThe Motley FoolActavis to buy Forest for $25 billion; windfall for investor Icahnhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.yahoo.com%2fnews%2factavis-buy-forest-labs-25-121026913.html&c=8578580037143988648&mkt=en-us(Reuters) - Generic drugmaker Actavis Plc (ACT.N) said on Tuesday it would buy Forest Laboratories Inc (NYS:FRX) for about $25 billion (14 billion pounds) in cash and stock, expanding its portfolio of ...Tue, 18 Feb 2014 09:20:00 GMTYahooActavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adultshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.fiercepharma.com%2fregulatory%2factavis-receives-fda-approval-for-viberzi-eluxadoline-for-treatment-of-irritable-bowel&c=15662844251194188721&mkt=en-us-First in class treatment for IBS-D treats hallmark symptoms of IBS-D; abdominal pain and diarrhea - IBS-D can be debilitating, affecting up to 15 million Americans, and there are limited therapeutic.Thu, 28 May 2015 03:26:00 GMTFiercePharmaActavis to launch novel pain medication in the UShttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2factavis-to-launch-novel-pain-medication-us&c=3800879075665649937&mkt=en-usActavis today announced that its US subsidiary, Actavis Inc, has entered into a binding letter of intent (LOI) with QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) to commercialize MoxDuo® IR in the ...Thu, 22 Dec 2011 01:49:00 GMTFiercePharmaActavis And Forest Labs Soaring On $25 Billion Deal As Carl Icahn Credits Activism For The Successhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a378fbecdfa4a29943d58fb887602e6&url=https%3a%2f%2fwww.forbes.com%2fsites%2fmaggiemcgrath%2f2014%2f02%2f18%2factavis-and-forest-labs-soaring-on-25-billion-deal-as-carl-icahn-credits-activism-for-the-success%2f&c=16258419443842061056&mkt=en-usGlobal pharmaceutical company Actavis, which focuses on producing generic versions of name-brand prescriptions, announced Tuesday morning that it is buying the America-based Forest Labs in a deal ...Tue, 18 Feb 2014 06:03:00 GMTForbes